TcLand Expression appoints two
New chairman and vp of marketing and commercial operations
The French pioneer in the development of gene expression biomarkers for unmet needs in transplantation and auto-immune disease, has also appointed Patrick Terry as chairman of the Board. Terry, a Board member since 2009, succeeds TcLand Expression ceo Alain Huriez, who had held the position since 2005.
Terry is co-founder of Genomic Health and a founder of the Personalised Medicine Coalition.
You may also like
Research & Development
![Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines]()
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines
Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Research & Development
![PharmNovo reports broader therapeutic potential for PN6047]()
PharmNovo reports broader therapeutic potential for PN6047
PharmNovo AB has announced new preclinical findings supporting the potential of PN6047 in migraine and opioid withdrawal syndrome. The findings were generated through the company's NIDA-funded collaboration with researchers at Washington University School of Medicine
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Research & Development
![Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality]()
Neuropsychiatric medicine reaches an inflexion point: regulation, science and the road to commercial reality
Shaped by accelerating regulatory support, expanding clinical evidence and growing institutional acceptance, psychedelic medicine is entering a pivotal phase, reports Joel Latham, Chief Executive Officer, President and Director at Incannex Healthcare Inc.
